Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

2ONE Labs Prevails in Trademark Dispute against IMB Zone Brand

Business by 2FIRSTS.ai
Dec.24.2024
2ONE Labs Prevails in Trademark Dispute against IMB Zone Brand
US nicotine pouch brand 2ONE Labs wins preliminary injunction in trademark dispute with Imperial Tobacco's Zone brand.

On December 23rd, the American nicotine pouch brand 2ONE Labs announced on its official website that the brand, in partnership with distributor Performance Plus Marketing, had achieved a favorable preliminary injunction (PI) ruling in a trademark dispute with the Imperial Tobacco brand Zone. According to a court order dated December 20th, 2024, Zone's nicotine pouches are prohibited from being shipped to trade partners in the United States.

 

The CEO of 2ONE Labs, Vincent Schuman, stated that

 

This ruling is significant as it prohibits Imperial Tobacco from continuing to sell Zone nicotine pouches in the United States until the ongoing 2ONE trademark lawsuit is resolved.

 

According to the judge's ruling, the defendant (Imperial) is prohibited from selling oral nicotine products with the Bullseye trademark or any similar symbol. (Case number: CV 24-08124-MWF(Ex) Title: 2ONE Labs Inc. et al v. ITG Brands, LLC et al)

 

We are pleased that the court has made the correct decision to approve this PI. This is an extraordinary remedy for 2ONE and sets the foundation for their victory in the trademark infringement lawsuit against Imperial Tobacco.

 

References:
[1] 2ONE Labs, Inc. Secures Federal Preliminary Injunction Against ITG Brands and Affiliates in Trademark Infringement Case
Also Read:
[1] 2ONE Labs Announces PMTA Submission Update, Nicotine Pouch Products Receive FDA 'Acceptance' Again
[2] U.S. nicotine pouch brand 2ONE Labs says 2ONE® gains FDA “approval”
[3] Lawsuit Filed Against Imperial Brands Over Trademark Infringement
#North America#United States#Legislation#Nicotine pouches

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
E-Cigarette Industry in Indonesia Expected to Create Up to 280,000 Jobs by 2030, Boosting Tax Revenue.
Sep.26 by 2FIRSTS.ai
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan factory has posted new production job openings, following earlier reports of a shutdown at its Zhuhai site.
Oct.15
2Firsts Observation｜U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations
2Firsts Observation｜U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations
The U.S. has tightened vaping regulations nationwide. The DOJ, FDA, CBP and DEA seized millions of illegal devices in the largest-ever enforcement action. Several states introduced new laws with registries, packaging limits, and criminal penalties, signaling a shift toward institutionalized regulation and higher compliance costs.
Oct.17
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
The UK High Court has granted U.S. e-cigarette manufacturer Juul Labs a permanent injunction against four Chinese companies, bringing an end to a five-year patent and trademark infringement case. The defendants — Greensun Technology, Ouch, Gaish, and Airsmo Tech — failed to respond to any court communications or legal filings.
Oct.30 by 2FIRSTS.ai
Samsung's battery explosion case proceeds as court finds manufacturer maintained “sufficient contacts” with the state
Samsung's battery explosion case proceeds as court finds manufacturer maintained “sufficient contacts” with the state
The Minnesota Court of Appeals has ruled that Samsung SDI Co., Ltd., a South Korean battery manufacturer, is subject to Minnesota jurisdiction in a product-liability case involving a vape battery explosion. The court found the company had “sufficient minimum contacts” with the state through extensive business activity.
Oct.20 by 2FIRSTS.ai
Related Topics
News Company
Related Read
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
2FIRSTS.ai
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
2Firsts Observation｜U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations
2Firsts Observation｜U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
2FIRSTS.ai
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
2FIRSTS.ai
Samsung's battery explosion case proceeds as court finds manufacturer maintained “sufficient contacts” with the state
Samsung's battery explosion case proceeds as court finds manufacturer maintained “sufficient contacts” with the state
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文